The Next Decade of Therapeutic Apheresis: Bridging Innovation, Evidence, and Global Access
Therapeutic Apheresis and Dialysis · 14.07.2026
DOI: 10.1002/1744-9987.70194 ↗Kurz gefasst
Editorial in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 14.07.2026. Verfasst von Rasheed A Balogun. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
The author is President of the International Society for Apheresis (ISFA) and was invited by the journal to contribute this editorial. Any opinions expressed are those of the author. The author discloses that he has been a Consultant for Nipro Medical Corporation. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
- Department of Pathology, University of Virginia, Charlottesville, Virginia, USA.
ORCID-Profile: Rasheed A Balogun
Zitieren
APA
Balogun, R. A. (2026). The Next Decade of Therapeutic Apheresis: Bridging Innovation, Evidence, and Global Access. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70194
Vancouver
Balogun RA. The Next Decade of Therapeutic Apheresis: Bridging Innovation, Evidence, and Global Access. Therapeutic Apheresis and Dialysis. 2026. doi:10.1002/1744-9987.70194
BibTeX
@article{Balogun2026,
author = {Balogun, Rasheed A},
title = {The Next Decade of Therapeutic Apheresis: Bridging Innovation, Evidence, and Global Access},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
doi = {10.1002/1744-9987.70194}
}
EUVIMED